Paul Tudor Jones's VRNA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 400,000 shares of Verona Pharma plc (VRNA) worth $42.68 M, representing 0.07% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in VRNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 311,676 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Verona Pharma plc (VRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Verona Pharma plc (VRNA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2025 | +88,324 | New Buy | 88,324 | $63.49 |
| Q2 2025 | -88,324 | Sold Out | 88,324 | $63.49 |
| Q3 2025 | +400,000 | New Buy | 400,000 | $106.71 |
Paul Tudor Jones's Verona Pharma plc Investment FAQs
Paul Tudor Jones first purchased Verona Pharma plc (VRNA) in Q1 2025, acquiring 88,324 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Verona Pharma plc (VRNA) for 3 quarters since Q1 2025.
Paul Tudor Jones's largest addition to Verona Pharma plc (VRNA) was in Q3 2025, adding 400,000 shares worth $42.68 M.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 400,000 shares of Verona Pharma plc (VRNA), valued at approximately $42.68 M.
As of the Q3 2025 filing, Verona Pharma plc (VRNA) represents approximately 0.07% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Verona Pharma plc (VRNA) was 400,000 shares, as reported at the end of Q3 2025.